Australia markets closed

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
37.50+0.35 (+0.94%)
At close: 04:00PM EDT
37.51 +0.01 (+0.03%)
After hours: 05:41PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
25,189
25,189
15,265
21,453
23,191
Selling general and administrative
13,481
13,481
9,844
10,806
8,758
Total operating expenses
38,670
38,670
25,109
32,259
31,949
Operating income or loss
-38,670
-38,670
-25,109
-32,259
-31,949
Total other income/expenses net
-2,896
-2,896
742
1,239
7,297
Income before tax
-38,988
-38,988
-24,067
-30,910
-24,639
Income from continuing operations
-38,988
-38,988
-24,067
-30,910
-24,639
Net income
-38,988
-38,988
-24,067
-30,910
-24,639
Net income available to common shareholders
-38,988
-38,988
-24,067
-30,910
-24,639
Basic EPS
-3.21
-
-2.87
-5.81
-5.85
Diluted EPS
-3.21
-
-2.87
-5.81
-5.85
Basic average shares
10,195
-
8,397
5,318
4,175
Diluted average shares
10,195
-
8,397
5,318
4,175